17 studies found for:    Open Studies | "Epistaxis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Epistaxis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Intranasal Bevacizumab for HHT-Related Epistaxis
Conditions: HHT;   Hereditary Hemorrhagic Telangiectasia;   Epistaxis;   Nose Bleeds;   Nasal Bleeding
Intervention: Drug: Bevacizumab
2 Recruiting Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: placebo
3 Unknown  A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
Condition: Epistaxis
Intervention: Procedure: Nasal Cautery
4 Unknown  Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
5 Not yet recruiting Management of Persistent Epistaxis Using Floseal Hemostatic Matrix
Condition: Epistaxis
Interventions: Device: Floseal Hemostatic Matrix;   Procedure: Traditional Nasal Packing
6 Recruiting Long Term Results and Complications After Epistaxis Treatment
Condition: Nosebleed (Epistaxis) - Posterior or Anterior
Intervention:
7 Recruiting Nasal Intubation Using a Parker Flex-tip Endotracheal Tube Compared to a Nasal RAE Tube
Condition: Epistaxis
Interventions: Device: Nasal Intubation with nasal RAE endotracheal tube;   Device: Nasal Intubation with Parker Flex-Tip endotracheal tube
8 Recruiting Hemoglobin and INR Out of Nose Blood
Condition: Epistaxis
Intervention:
9 Recruiting Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Conditions: Nasal Obstruction;   Rhinitis, Vasomotor;   Epistaxis
Intervention: Other: Saline mixture
10 Recruiting The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
Conditions: Epistaxis;   Blood Pressure
Interventions: Drug: Oxymetazoline 0.05%;   Drug: Phenylephrine 0.25%;   Drug: Lidocaine 1% plus epinephrine 1:100,000;   Drug: Bacteriostatic 0.9% NaCL
11 Unknown  Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy
Conditions: Anesthesia;   Epistaxis
Interventions: Device: Double pledget nasal anesthesia (DPNA);   Device: Single pledget nasal anesthesia (SPNA)
12 Unknown  Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
13 Unknown  A Novel Anterior Rhinoscopic Scoring Scale to Predict Nasal Insertability Before Transnasal Endoscopy
Conditions: Injury Due to Endoscopic Examination;   Transnasal Endoscopy Induced Epistaxis;   Transnasal Endoscopy Induced Nasal Pain
Interventions: Procedure: anterior meatoscopy;   Procedure: Nasal sniff test
14 Unknown  Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
15 Recruiting Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Condition: Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions: Drug: Timolol nasal spray;   Drug: Placebo nasal spray
16 Recruiting Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention: Drug: bevacuzimab spray
17 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet

Indicates status has not been verified in more than two years